Rtw Investments, Lp

Source: SEC Form 13F · as of Mar 2026

Rtw Investments, Lp holds 71 biotech & pharma companies tracked by BioSniper, totaling $8.58B in value as of Mar 2026 (SEC Form 13F).

Companies held

71

Total value held

$8.58B

CompanySharesValue
MDGLMADRIGAL PHARMACEUTICALS, INC.1,993,687$1.04B
INSMINSMED Inc4,842,880$791.9M
PTGXProtagonist Therapeutics, Inc5,059,053$533.2M
PTCTPTC THERAPEUTICS, INC.7,746,415$527.8M
ARGXARGENX SE709,446$518.1M
CGONCG Oncology, Inc.6,984,808$472.7M
TNGXTango Therapeutics, Inc.13,300,620$278.2M
ERASErasca, Inc.16,157,175$261.4M
TARSTarsus Pharmaceuticals, Inc.3,346,025$234.7M
APGEApogee Therapeutics, Inc.2,782,097$234.2M
SYRESpyre Therapeutics, Inc.4,171,996$210.4M
COGTCogent Biosciences, Inc.5,458,675$210.1M
STOKStoke Therapeutics, Inc.5,623,525$183.1M
CYTKCYTOKINETICS INC2,721,158$179.4M
ACADACADIA PHARMACEUTICALS INC7,144,524$159.0M
APLSApellis Pharmaceuticals, Inc.3,685,045$148.2M
IMCRImmunocore Holdings plc4,869,798$146.8M
RGENREPLIGEN CORP1,206,000$142.1M
NBIXNEUROCRINE BIOSCIENCES INC1,062,072$139.9M
GHGuardant Health Inc.1,481,033$136.8M
IMTXImmatics N.V.12,869,340$126.6M
ZLABZai Lab Ltd6,574,032$123.7M
BLTEBELITE BIO, INC715,332$114.1M
ORKAOruka Therapeutics, Inc.2,058,148$101.0M
GHRSGH Research PLC5,933,815$83.4M
XNCRXencor Inc6,777,461$81.7M
URGNUroGen Pharma Ltd.4,543,895$81.7M
CNTACentessa Pharmaceuticals plc2,054,175$81.6M
IMVTImmunovant, Inc.3,177,849$78.9M
RAREUltragenyx Pharmaceutical Inc.3,648,795$76.4M
CSTLCastle Biosciences Inc.2,758,335$67.7M
RCKTRocket Pharmaceuticals Inc.17,687,772$63.3M
TSHATaysha Gene Therapies, Inc.13,680,248$61.2M
ALKSAlkermes plc.1,672,356$59.1M
CMPSCOMPASS Pathways plc10,632,390$58.8M
KODKodiak Sciences Inc.1,487,934$56.7M
REPLReplimune Group, Inc.7,356,916$56.3M
CRNXCrinetics Pharmaceuticals, Inc.1,451,326$52.7M
QUREuniQure N.V.2,586,356$42.3M
ARWRARROWHEAD PHARMACEUTICALS, INC.585,682$36.7M
OBIOOrchestra BioMed Holdings Inc.8,306,063$35.3M
VSTMVerastem, Inc.6,576,306$34.9M
EVMNEvommune, Inc.1,502,235$34.5M
SVRASavara Inc5,952,380$32.5M
CADLCandel Therapeutics, Inc.6,422,018$31.5M
AQSTAquestive Therapeutics, Inc.7,426,471$30.8M
AKTSAktis Oncology Inc.1,592,043$28.5M
NGNENeurogene Inc.1,362,456$27.5M
CGEMCullinan Therapeutics, Inc.1,705,960$24.2M
CMPXCompass Therapeutics, Inc.4,186,599$22.1M
DNTHDianthus Therapeutics, Inc. /DE/248,063$20.8M
FLGTFulgent Genetics Inc.1,289,000$20.5M
BBNXBeta Bionics Inc.2,000,000$20.0M
KYMRKymera Therapeutics, Inc.240,000$20.0M
IPSCCentury Therapeutics, Inc.8,695,652$19.7M
BEAMBeam Therapeutics Inc.570,394$13.6M
AVTXAvalo Therapeutics, Inc.856,962$12.8M
OCGNOcugen, Inc.6,666,666$12.1M
WVEWave Life Sciences Ltd.1,350,000$9.8M
JBIOJade Biosciences, Inc.573,205$8.1M
CAPRCAPRICOR THERAPEUTICS, INC.250,000$7.6M
MISTMilestone Pharmaceuticals Inc.6,331,001$7.5M
KLRSKalaris Therapeutics, Inc.1,300,000$7.5M
IVAInventiva S.A.1,298,702$7.2M
ATAIAtai Beckley N.V.2,000,000$7.1M
CBIOCRESCENT BIOPHARMA, INC.372,856$6.8M
LRMRLarimar Therapeutics, Inc.1,500,000$6.8M
DFTXDefinium Therapeutics Inc.300,000$5.7M
FDMT4D Molecular Therapeutics, Inc.475,737$4.4M
IRONDisc Medicine, Inc.30,000$1.9M
IMAImageneBio, Inc.334,445$1.7M

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.